Tumor Antigen ROR1 targeted delivery of MiR-29b in chronic lymphocytic leukemia induces epigenetic reprograming resulting in cell cycle arrest and therapeutic benefit in-vivo
LEUKEMIA & LYMPHOMA（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要